The parapoxvirus Orf virus (ORFV) encodes several immunomodulatory proteins (IMPs) that modulate host-innate and pro-inflammatory responses and has been proposed as a vaccine delivery vector for use in animal species. Here we describe the construction and characterization of two recombinant ORFV vectors expressing the rabies virus (RABV) glycoprotein (G). The RABV-G gene was inserted in the ORFV024 or ORFV121 gene loci， which encode for IMPs that are unique to parapoxviruses and inhibit activation of the NF-κB signaling pathway. The immunogenicity of the resultant recombinant viruses (ORFVRABV-G or ORFVRABV-G， respectively) was evaluated in pigs and cattle. Immunization of the target species with ORFVRABV-... More
The parapoxvirus Orf virus (ORFV) encodes several immunomodulatory proteins (IMPs) that modulate host-innate and pro-inflammatory responses and has been proposed as a vaccine delivery vector for use in animal species. Here we describe the construction and characterization of two recombinant ORFV vectors expressing the rabies virus (RABV) glycoprotein (G). The RABV-G gene was inserted in the ORFV024 or ORFV121 gene loci， which encode for IMPs that are unique to parapoxviruses and inhibit activation of the NF-κB signaling pathway. The immunogenicity of the resultant recombinant viruses (ORFVRABV-G or ORFVRABV-G， respectively) was evaluated in pigs and cattle. Immunization of the target species with ORFVRABV-G and ORFVRABV-G elicited robust neutralizing antibody responses against RABV. Notably， neutralizing antibody titers induced in ORFVRABV-G-immunized pigs and cattle were significantly higher than those detected in ORFVRABV-G-immunized animals， indicating a higher immunogenicity of ORFV-based vectors in these animal species.
